Overview

Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)

Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
This study will compare 2 treatments in the way they affect cholesterol levels and the amount of HIV in the blood.
Phase:
Phase 3
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Atazanavir Sulfate
HIV Protease Inhibitors
Lopinavir
Protease Inhibitors
Ritonavir